Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that ... Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.58 | -5.73122529644 | 10.12 | 10.157161 | 9.22 | 77372 | 9.61663937 | CS |
| 4 | -0.78 | -7.55813953488 | 10.32 | 13.34 | 9.22 | 117679 | 10.74221382 | CS |
| 12 | 0.36 | 3.92156862745 | 9.18 | 13.34 | 7.17 | 79302 | 9.6591254 | CS |
| 26 | 2.76 | 40.7079646018 | 6.78 | 13.34 | 6.47 | 72445 | 8.99602183 | CS |
| 52 | 0.55 | 6.11790878754 | 8.99 | 13.34 | 5.55 | 100279 | 7.70358454 | CS |
| 156 | -7.91 | -45.329512894 | 17.45 | 18.65 | 4.44 | 99490 | 8.20498293 | CS |
| 260 | 5.59 | 141.518987342 | 3.95 | 20.92 | 3.08 | 162109 | 7.86328512 | CS |
spindog
4年前
kkballa
4年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。